630 results on '"Danon disease"'
Search Results
2. A novel frameshift variant in <italic>LAMP2</italic> gene mimicking choroideremia carrier retinopathy.
- Author
-
Narayan, Akshay, Taylor, Laura J., Sperring, Sian, Shanks, Morag, Clouston, Penny, MacLaren, Robert E., and Cehajic-Kapetanovic, Jasmina
- Subjects
- *
HEARING disorders , *GENETIC variation , *CHOROIDEREMIA , *RETINAL diseases , *GENETIC testing , *EXOMES , *RHODOPSIN - Abstract
BackgroundMethodsResultsConclusionDanon disease is a rare, multisystemic X-linked dominant disorder caused by variants in the
LAMP2 gene. It can be associated with retinal degeneration, but this is not well characterized. Here we describe a late presentation of a mild retinal phenotype, initially diagnosed as choroideremia carrier, associated with a novel variant in theLAMP2 gene.Retrospective analysis of the case included medical history, ophthalmic examination, multimodal retinal imaging, and microperimetry. Genetic testing was conducted to establish the molecular diagnosis.A 54-year-old female presented with worsening night vision, without any family history. BCVA was 6/6 bilaterally and fundus examination showed light peripheral pigmentary changes bilaterally. FAF demonstrated a widespread speckled pattern and OCT revealed hyper-reflective spots in the outer nuclear layer. Differentials included non-genetic and genetic causes, suspected of being a manifesting choroideremia carrier. However, initial genetic testing by targeted analysis of retinal disorders did not detect a pathogenic variant. Further systems review revealed that the patient had previously been diagnosed with dilated cardiomyopathy, mini-stroke and partial deafness. Subsequent whole mitochondrial genome sequencing analysis did not detect any pathogenic variants too. Finally, whole exome sequencing with targeted analysis of a panel of hypertrophic cardiomyopathy genes identified a novel pathogenic heterozygous variant (c.925del, p.(Ser309fs)) in theLAMP2 gene, confirming the diagnosis of X-linked Danon disease.Recording previous medical history and extraocular symptoms is crucial. The similarity in choroideremia carrier and Danon disease retinal phenotypes suggests a possible common pathway in these two genes where pathogenic variants lead to retinal pigment epithelium degeneration. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
3. Natural History of Danon Disease
- Published
- 2023
4. A Multi-Center, Open Label Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Published
- 2023
5. Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
- Published
- 2023
6. A Mutational Hotspot in The LAMP2 Gene: Unravelling Intrafamilial Phenotypic Variation and Global Distribution of The c.877C>T Variant: A Descriptive Study
- Author
-
Saeideh Kavousi, Mohammad Dalili, Bahareh Rabbani, Mehrdad Behmanesh, Mehrdad Noruzinia, and Nejat Mahdieh
- Subjects
danon disease ,next-generation sequencing ,cardiomyopathy ,Medicine ,Science - Abstract
Objective: Danon disease is defined by a clinical trio of cardiomyopathy, skeletal myopathy, and cognitive impairment.It results from the lysosomal-associated membrane protein-2 (LAMP2) gene variants. The aim of study is determinationof genotype and phenotype of a newly diagnosed Iranian family with a unique phenotype due to a pathogenic variantof the LAMP2 gene along with a phenotypic comparison of all reported patients.Materials and Methods: In this descriptive study, we evaluated the demographic data, clinical features, managementprocedures, as well as genetic analysis of both patients in this newly diagnosed family. Whole genome sequencing(WGS) and in silico structural and functional predictions were applied. A comprehensive search of the c.877C>T variantin LAMP2 was conducted using the PubMed, Google Scholar, VarSome, ClinVar, Human Gene Mutation Database(HGMD), and Franklin databases to identify any genotype-phenotype correlations.Results: Nine patients were carriers of the c.877C>T variant. All patients were male, and displayed variable degreesof left ventricular hypertrophy (LVH) that ranged from mild to severe. All patients exhibited typical cardiac conductionabnormalities consistent with Danon disease. Four underwent heart transplants and survived. Skeletal muscleinvolvement and cognitive impairment were observed in four patients each. The mean age of onset was 14 years. Theproband in this study exhibited an earlier onset of cardiac symptoms.Conclusion: Genetic analysis is the preferred diagnosis approach for Danon disease and can assist families inmanaging affected patients, identify carriers, and assist with future family planning. This study highlights the intrafamilialphenotypic variability of Danon disease. It is possible that variants of this gene may be frequent in Iran.
- Published
- 2024
- Full Text
- View/download PDF
7. A Mutational Hotspot in The LAMP2 Gene: Unravelling Intrafamilial Phenotypic Variation and Global Distribution of The c.877C>T Variant: A Descriptive Study.
- Author
-
Kavousi, Saeideh, Dalili, Mohammad, Rabbani, Bahareh, Behmanesh, Mehrdad, Noruzinia, Mehrdad, and Mahdieh, Nejat
- Subjects
- *
PHENOTYPIC plasticity , *LEFT ventricular hypertrophy , *WHOLE genome sequencing , *GENETIC variation , *HEART transplantation - Abstract
Objective: Danon disease is defined by a clinical trio of cardiomyopathy, skeletal myopathy, and cognitive impairment. It results from the lysosomal-associated membrane protein-2 (LAMP2) gene variants. The aim of study is determination of genotype and phenotype of a newly diagnosed Iranian family with a unique phenotype due to a pathogenic variant of the LAMP2 gene along with a phenotypic comparison of all reported patients. Materials and Methods: In this descriptive study, we evaluated the demographic data, clinical features, management procedures, as well as genetic analysis of both patients in this newly diagnosed family. Whole genome sequencing (WGS) and in silico structural and functional predictions were applied. A comprehensive search of the c.877C>T variant in LAMP2 was conducted using the PubMed, Google Scholar, VarSome, ClinVar, Human Gene Mutation Database (HGMD), and Franklin databases to identify any genotype-phenotype correlations. Results: Nine patients were carriers of the c.877C>T variant. All patients were male, and displayed variable degrees of left ventricular hypertrophy (LVH) that ranged from mild to severe. All patients exhibited typical cardiac conduction abnormalities consistent with Danon disease. Four underwent heart transplants and survived. Skeletal muscle involvement and cognitive impairment were observed in four patients each. The mean age of onset was 14 years. The proband in this study exhibited an earlier onset of cardiac symptoms. Conclusion: Genetic analysis is the preferred diagnosis approach for Danon disease and can assist families in managing affected patients, identify carriers, and assist with future family planning. This study highlights the intrafamilial phenotypic variability of Danon disease. It is possible that variants of this gene may be frequent in Iran. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Altered Splicing of LAMP2 in a Multigenerational Family from Latvia Affected by Danon Disease.
- Author
-
Stavusis, Janis, Micule, Ieva, Grinfelde, Ieva, Zdanovica, Anna, Pudulis, Janis, Valeina, Sandra, Sepetiene, Svetlana, Lace, Baiba, and Inashkina, Inna
- Subjects
MYOCARDIUM ,HYPERTROPHIC cardiomyopathy ,NUCLEOTIDE sequencing ,GENETIC variation ,CARDIAC patients ,INTELLECTUAL disabilities - Abstract
Background and Objectives: Danon disease is a multisystemic disorder associated with variants in the LAMP2 gene, mainly affecting the cardiac muscle. Here, we report a multigenerational family from Latvia with two male patients, hemizygous for a novel splice-affecting variant c.928+3A>G. Affected patients exhibit a cardiac phenotype, moderate mental disability, and mild retinal changes. Materials and Methods: Both patients underwent either exome or hypertrophic cardiomyopathy gene panel next-generation sequencing. The pathogenic variant effect was determined using reverse transcription, Sanger sequencing, and high-resolution electrophoresis. Results: Evaluation of the splicing process revealed that approximately 80% of the transcripts exhibited a lack of the entire exon 7. This alteration was predicted to cause a shift of the reading frame, consequently introducing a premature stop codon downstream in the sequence. Conclusions: Based on our data, we propose that c.928+3A>G is a pathogenic variant associated with Danon disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Corrigendum: Cardiovascular magnetic resonance findings in Danon disease: a case series of a family
- Author
-
Xiaolong Liu, Ning Zhai, Xiaoqiang Wang, Jiehuan Wang, Mengchun Jiang, Zhanguo Sun, Yueqin Chen, Jingjing Xu, Yinghua Cui, and Lu Li
- Subjects
Danon disease ,glycogen storage disease ,LAMP2 ,cardiovascular magnetic resonance ,late gadolinium enhancement ,feature tracking ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2024
- Full Text
- View/download PDF
10. Case Report: Multiple types of arrhythmias in a late-confirmed Danon disease
- Author
-
Nan Wang, Yu Cao, Jie Wang, and Qing Zhang
- Subjects
Danon disease ,arrhythmia ,Wolff–Parkinson–White (WPW) syndrome ,LAMP2 variant ,case report ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
IntroductionDanon disease is an X-linked disorder caused by pathogenic variants in lysosome-associated membrane protein 2 (LAMP2) gene, typically characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. However, many patients may not present the typical presentation, especially in the early stage. Electrocardiogram (ECG) abnormalities can be found in almost all patients, with Wolff–Parkinson–White (WPW) syndrome being the most common. We reported the case of a 51-year-old woman who experienced multiple types of arrhythmias over three decades and was diagnosed with Danon disease late by genetic testing.Case summaryA 51-year-old woman with a 36-year history of intermittent palpitations was admitted due to hemodynamically stable ventricular tachycardia (VT). Her past medical history revealed multiple arrhythmias and ECG abnormalities in her 30s and 40s, including WPW syndrome with paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, atrial fibrillation, ventricular tachycardia, and complete left bundle branch block. She denied any family history of cardiovascular disease or sudden death. Upon arrival, her vital signs were unremarkable. Cardiovascular magnetic resonance (CMR) imaging revealed left ventricular enlargement and late gadolinium enhancement (LGE) in the anterior, inferior, and lateral walls. Subsequent, whole-exome sequencing (WES) gene testing revealed a pathogenic heterozygous variant in LAMP2 gene (c.696T>A; p.Cys232Ter), which confirmed the diagnosis of Danon disease.ConclusionGenetic testing should be considered in patients who display multiple arrhythmias with LV structural abnormalities of unknown etiology for a possible Danon disease.
- Published
- 2024
- Full Text
- View/download PDF
11. A Case Study and Literature Review of the Diagnosis of Danon Disease in Patients Presenting Only with Severe Cardiac Symptoms
- Author
-
Sun YQ, Lv Q, Chen D, Da Y, Zhao XY, and Dong JZ
- Subjects
danon disease ,cardiomyopathy ,serum cardiac troponin i ,management ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Yu-Qing Sun,1 Qiang Lv,1 Dong Chen,2 Yuwei Da,3 Xiao-Yan Zhao,4 Jian-Zeng Dong1 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung & Blood Vessel Diseases, Beijing, People’s Republic of China; 2Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung & Blood Vessel Diseases, Beijing, People’s Republic of China; 3Department of Neurology, Beijing Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 4Department of Cardiology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan, People’s Republic of ChinaCorrespondence: Jian-Zeng Dong, Email jz_dong@126.comAbstract: The clinical manifestations of Danon disease, which result from the primary deficiency of the lysosome-associated membrane protein 2 gene, include cardiomyopathy, skeletal myopathy, and different degrees of intellectual disability that vary greatly among patients. The present study reports on two cases of Danon disease in two patients who only presented cardiac symptoms. Cardiac symptoms usually occur in adolescence and during a patient’s twenties, and most patients die from heart failure. However, the lab results from these cases suggested that other systems were involved, despite no other clinical symptoms. Significantly, the two patients had elevated serum cardiac troponin I, which often manifests in the acute cardiac phase, especially in severely affected patients with rapidly fatal outcomes. Danon disease is a multi-system involvement disease. Therefore, clinicians must be aware of its complexity when evaluating newly diagnosed patients due to its vastly different clinical course and prognosis and the importance of multidisciplinary management.Keywords: Danon disease, cardiomyopathy, serum cardiac troponin I, management
- Published
- 2023
12. Clinical manifestations and MRI features of Danon disease: a case series
- Author
-
Yang Zhang, Ren Zhao, Yushan Yuan, Yongqiang Yu, Bin Liu, and Xiaohu Li
- Subjects
Danon disease ,Magnetic resonance imaging ,Extracellular volume fraction ,T1 mapping ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Danon disease (DD) is an exceptionally uncommon X-linked dominant lysosomal glycogen storage disorder characterized by pronounced ventricular hypertrophy and cardiac insufficiency. The timely identification of cardiac impairment in individuals with DD holds significant clinical importance. Case presentation We present a case of Danon Disease in a three-generation pedigree from Anhui Province, China. Clinical features and laboratory data were collected and analyzed for a 16-year-old male proband (III-1) and two affected female family members (II-2 and II-3). The proband exhibited Wolf-Parkinson-White syndrome, hypertrophic cardiomyopathy, abnormal cognitive function, and muscle weakness. Gene sequencing confirmed a mutation (c.963G > A) in the LAMP-2 gene. Conclusion Patients with DD may present both dilated and hypertrophic cardiomyopathy. Comprehensive myocardial tissue characterization by MRI plays a key role in the diagnosis of the disease.
- Published
- 2023
- Full Text
- View/download PDF
13. Identification of a novel splicing‐altering LAMP2 variant in a Chinese family with Danon disease
- Author
-
Di Fu, Shuai Wang, Yonghong Luo, Sha Wu, and Daoquan Peng
- Subjects
Danon disease ,LAMP2 ,Splicing mutation ,Genetic diagnosis ,Minigene assay ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims This study aimed to identify a novel splicing‐altering LAMP2 variant associated with Danon disease. Methods and results To identify the potential genetic mutation in a Chinese pedigree, whole‐exome sequencing was conducted in the proband, and Sanger sequencing was performed on the proband's parents. To verify the impact of the splice‐site variant, a minigene splicing assay was applied. The AlphaFold2 analysis was used to analyse the mutant protein structure. A splice‐site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified as a potential pathogenic variant. The minigene splicing revealed that this variant causes exon 6 to be skipped, resulting in a truncated protein. The AlphaFold2 analysis showed that the mutation caused a protein twist direction change, leading to conformational abnormality. Conclusions A novel splice‐site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified. This discovery may enlarge the LAMP2 variant spectrum, promote accurate genetic counselling, and contribute to the diagnosis of Danon disease.
- Published
- 2023
- Full Text
- View/download PDF
14. The Natural History of Danon Disease
- Author
-
Rocket Pharmaceuticals Inc. and Eric Adler, MD, Professor of Medicine
- Published
- 2022
15. Molecular Pathology of the Heart and Cardiovascular System
- Author
-
(Rex) Hung, Yin P., Stone, James R., Cheng, Liang, editor, Netto, George J., editor, and Eble, John N., editor
- Published
- 2023
- Full Text
- View/download PDF
16. International Consensus on Differential Diagnosis and Management of Patients With Danon Disease: JACC State-of-the-Art Review.
- Author
-
Hong, Kimberly N., Eshraghian, Emily A., Arad, Michael, Argirò, Alessia, Brambatti, Michela, Bui, Quan, Caspi, Oren, de Frutos, Fernando, Greenberg, Barry, Ho, Carolyn Y., Kaski, Juan Pablo, Olivotto, Iacopo, Taylor, Matthew R.G., Yesso, Abigail, Garcia-Pavia, Pablo, and Adler, Eric D.
- Subjects
- *
HEART failure , *CARDIAC hypertrophy , *DIFFERENTIAL diagnosis , *DIAGNOSIS , *OCULAR manifestations of general diseases , *VENTRICULAR arrhythmia - Abstract
Danon disease is a rare X-linked autophagic vacuolar cardioskeletal myopathy associated with severe heart failure that can be accompanied with extracardiac neurologic, skeletal, and ophthalmologic manifestations. It is caused by loss of function variants in the LAMP2 gene and is among the most severe and penetrant of the genetic cardiomyopathies. Most patients with Danon disease will experience symptomatic heart failure. Male individuals generally present earlier than women and die of either heart failure or arrhythmia or receive a heart transplant by the third decade of life. Herein, the authors review the differential diagnosis of Danon disease, diagnostic criteria, natural history, management recommendations, and recent advances in treatment of this increasingly recognized and extremely morbid cardiomyopathy. [Display omitted] • Danon disease is a rare, X-linked genetic cardiomyopathy in which protein deficiency results in autophagy, accumulation of autophagosomes, defective mitochondria myocyte death, and adverse clinical outcomes. • Clinical features include myocardial hypertrophy, conduction abnormalities, heart failure, malignant ventricular arrhythmia, and multisystem involvement. • Understanding the pathophysiology and clinical trajectory of Danon disease may promote earlier diagnosis, risk stratification, and patient selection for medical and gene therapies that may have implications for other genetic cardiomyopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease.
- Author
-
Wang, Yongxiang, Bai, Ming, Zhang, Piyi, Peng, Yu, Chen, Zixian, He, Zhiyu, Xu, Jin, Zhu, Youqi, Yan, Dongdong, Wang, Runqing, and Zhang, Zheng
- Subjects
- *
X chromosome , *MISSENSE mutation , *FUNCTIONAL analysis , *GREEN fluorescent protein , *CARDIAC magnetic resonance imaging , *MOLECULAR biology - Abstract
Background: Danon disease is characterized by the failure of lysosomal biogenesis, maturation, and function due to a deficiency of lysosomal membrane structural protein (LAMP2). Methods: The current report describes a female patient with a sudden syncope and hypertrophic cardiomyopathy phenotype. We identified the pathogenic mutations in patients by whole‐exon sequencing, followed by a series of molecular biology and genetic approaches to identify and functional analysis of the mutations. Results: Suggestive findings by cardiac magnetic resonance (CMR), electrocardiogram (ECG), and laboratory examination suggested Danon disease which was confirmed by genetic testing. The patient carried a novel de novo mutation, LAMP2 c.2T>C located at the initiation codon. The quantitative polymerase chain reaction (qPCR) and Western blot (WB) analysis of peripheral blood leukocytes from the patients revealed evidence of LAMP2 haploinsufficiency. Labeling of the new initiation codon predicted by the software with green fluorescent protein followed by fluorescence microscopy and Western blotting showed that the first ATG downstream from the original initiation codon became the new translational initiation codon. The three‐dimensional structure of the mutated protein predicted by alphafold2 revealed that it consisted of only six amino acids and failed to form a functional polypeptide or protein. Overexpression of the mutated LAMP2 c.2T>C showed a loss of function of the protein, as assessed by the dual‐fluorescence autophagy indicator system. The mutation was confirmed to be null, AR experiments and sequencing results confirmed that 28% of the mutant X chromosome remained active. Conclusion: We propose possible mechanisms of mutations associated with haploinsufficiency of LAMP2: (1) The inactivation X chromosome carrying the mutation was not significantly skewed. However, it decreased in the mRNA level and the expression ratio of the mutant transcripts; (2) The identified mutation is null, and the active mutant transcript fails to translate into the normal LAMP2 proteins. The presence of haploinsufficiency in LAMP2 and the X chromosome inactivation pattern were crucial factors contributing to the early onset of Danon disease in this female patient. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.
- Author
-
Burban, Anna, Pucyło, Szymon, Sikora, Aleksandra, Opolski, Grzegorz, Grabowski, Marcin, and Kołodzińska, Agnieszka
- Subjects
- *
HYPERTROPHIC cardiomyopathy , *CARDIOMYOPATHIES , *CARDIAC hypertrophy , *THERAPEUTICS , *GLYCOGEN storage disease type II , *HEART - Abstract
One of the main causes of heart failure is cardiomyopathies. Among them, the most common is hypertrophic cardiomyopathy (HCM), characterized by thickening of the left ventricular muscle. This article focuses on HCM and other cardiomyopathies with myocardial hypertrophy, including Fabry disease, Pompe disease, and Danon disease. The genetics and pathogenesis of these diseases are described, as well as current and experimental treatment options, such as pharmacological intervention and the potential of gene therapies. Although genetic approaches are promising and have the potential to become the best treatments for these diseases, further research is needed to evaluate their efficacy and safety. This article describes current knowledge and advances in the treatment of the aforementioned cardiomyopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Clinical manifestations and MRI features of Danon disease: a case series.
- Author
-
Zhang, Yang, Zhao, Ren, Yuan, Yushan, Yu, Yongqiang, Liu, Bin, and Li, Xiaohu
- Subjects
SYMPTOMS ,GLYCOGEN storage disease type II ,HEART failure ,CARDIAC hypertrophy ,HYPERTROPHIC cardiomyopathy ,DIAGNOSIS - Abstract
Background: Danon disease (DD) is an exceptionally uncommon X-linked dominant lysosomal glycogen storage disorder characterized by pronounced ventricular hypertrophy and cardiac insufficiency. The timely identification of cardiac impairment in individuals with DD holds significant clinical importance. Case presentation: We present a case of Danon Disease in a three-generation pedigree from Anhui Province, China. Clinical features and laboratory data were collected and analyzed for a 16-year-old male proband (III-1) and two affected female family members (II-2 and II-3). The proband exhibited Wolf-Parkinson-White syndrome, hypertrophic cardiomyopathy, abnormal cognitive function, and muscle weakness. Gene sequencing confirmed a mutation (c.963G > A) in the LAMP-2 gene. Conclusion: Patients with DD may present both dilated and hypertrophic cardiomyopathy. Comprehensive myocardial tissue characterization by MRI plays a key role in the diagnosis of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation—Case Report and Review of the Literature.
- Author
-
Shalata, Adel, Bar-Shai, Marina, Hadid, Yarin, Mahroum, Muhammad, Mintz, Hila, Shalata, Zaher Eldin, Radzishevsky, Evgeny, Genizi, Jacob, Lorber, Avraham, Ben-Yosef, Tamar, and Yaniv, Liat
- Subjects
- *
SYMPTOMS , *LITERATURE reviews , *DELETION mutation , *LEFT ventricular hypertrophy , *RETINAL degeneration , *AGENESIS of corpus callosum - Abstract
Danon disease is a rare x-linked dominant multisystemic disorder with a clinical triad of severe cardiomyopathy, skeletal myopathy, and intellectual disability. It is caused by defects in the lysosome-associated membrane protein-2 (LAMP2) gene. Numerous different mutations in the LAMP2 protein have been described. Danon disease is typically lethal by the mid-twenties in male patients due to cardiomyopathy and heart failure. Female patients usually present with milder and variable symptoms. This report describes a 42-year-old father and his 3-year-old daughter presenting with mild manifestations of the disease. The father has normal intellectual development and normal physical activity. At the age of 13, he was diagnosed with mild ventricular pre-excitation known as Wolf–Parkinson–White syndrome (WPWs), very mild and mostly asymptomatic cardiomyopathy and left ventricular hypertrophy, and at about the age of 25 presented with visual impairment due to cone–rod dystrophy. His daughter showed normal development and very mild asymptomatic electrocardiographic WPWs abnormalities with left mild ventricular hypertrophy. Genetic testing revealed an Xq24 microdeletion encompassing the entire LAMP2 gene. Relevant literature was reviewed as a reference for the etiology, diagnosis, treatment and case management. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Beyond vacuolar pathology: Multiomic profiling of Danon disease reveals dysfunctional mitochondrial homeostasis.
- Author
-
Kleefeld, Felix, Hentschel, Andreas, von Moers, Arpad, Hahn, Katrin, Horvath, Rita, Goebel, Hans‐Hilmar, Preusse, Corinna, Schallner, Jens, Schuelke, Markus, Roos, Andreas, and Stenzel, Werner
- Subjects
- *
UBIQUITINATION , *LYSOSOMES , *HOMEOSTASIS , *MITOCHONDRIA , *X-linked genetic disorders , *UBIQUITIN ligases - Abstract
Interestingly, although both patients showed a complete LAMP2 protein deficiency, vacuoles were not visible on light microscopy in the muscle of patient I. This may be due to his young age because the formation of vacuoles and the development of a full picture of DD is a time-dependent process. X-axis shows fold change of mRNA abundance [FPKM] in DD-patients while Y-axis shows fold change of protein abundance (arbitrary units) in patients suffering from DD. Keywords: Danon disease; LAMP2; mitophagy; proteomics; transcriptomics EN Danon disease LAMP2 mitophagy proteomics transcriptomics 1 7 7 09/01/23 20230801 NES 230801 Key points Danon disease is characterised by both vacuolar myopathy and impaired mitochondrial turnover, evident at the morphological, mRNA and protein levels. 184 rows, 5 columns, T-test between DD-patients and Controls p < 0.05 (B) mRNA investigation: DD-patients (n = 2) versus Controls (n = 4) => 14,334 mRNA species included. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
22. Identification of a novel splicing‐altering LAMP2 variant in a Chinese family with Danon disease.
- Author
-
Fu, Di, Wang, Shuai, Luo, Yonghong, Wu, Sha, and Peng, Daoquan
- Subjects
MUTANT proteins ,GENETIC counseling ,PROTEIN structure ,GENETIC mutation ,FAMILIES - Abstract
Aims: This study aimed to identify a novel splicing‐altering LAMP2 variant associated with Danon disease. Methods and results: To identify the potential genetic mutation in a Chinese pedigree, whole‐exome sequencing was conducted in the proband, and Sanger sequencing was performed on the proband's parents. To verify the impact of the splice‐site variant, a minigene splicing assay was applied. The AlphaFold2 analysis was used to analyse the mutant protein structure. A splice‐site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified as a potential pathogenic variant. The minigene splicing revealed that this variant causes exon 6 to be skipped, resulting in a truncated protein. The AlphaFold2 analysis showed that the mutation caused a protein twist direction change, leading to conformational abnormality. Conclusions: A novel splice‐site variant (NM_013995.2:c.864+5G>A) located at intron 6 of the LAMP2 gene was identified. This discovery may enlarge the LAMP2 variant spectrum, promote accurate genetic counselling, and contribute to the diagnosis of Danon disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease
- Author
-
Yongxiang Wang, Ming Bai, Piyi Zhang, Yu Peng, Zixian Chen, Zhiyu He, Jin Xu, Youqi Zhu, Dongdong Yan, Runqing Wang, and Zheng Zhang
- Subjects
autophagy ,Danon disease ,haploinsufficiency ,initiation codon mutation ,lysosome‐associated membrane glycoprotein 2 ,X chromosome inactivation ,Genetics ,QH426-470 - Abstract
Abstract Background Danon disease is characterized by the failure of lysosomal biogenesis, maturation, and function due to a deficiency of lysosomal membrane structural protein (LAMP2). Methods The current report describes a female patient with a sudden syncope and hypertrophic cardiomyopathy phenotype. We identified the pathogenic mutations in patients by whole‐exon sequencing, followed by a series of molecular biology and genetic approaches to identify and functional analysis of the mutations. Results Suggestive findings by cardiac magnetic resonance (CMR), electrocardiogram (ECG), and laboratory examination suggested Danon disease which was confirmed by genetic testing. The patient carried a novel de novo mutation, LAMP2 c.2T>C located at the initiation codon. The quantitative polymerase chain reaction (qPCR) and Western blot (WB) analysis of peripheral blood leukocytes from the patients revealed evidence of LAMP2 haploinsufficiency. Labeling of the new initiation codon predicted by the software with green fluorescent protein followed by fluorescence microscopy and Western blotting showed that the first ATG downstream from the original initiation codon became the new translational initiation codon. The three‐dimensional structure of the mutated protein predicted by alphafold2 revealed that it consisted of only six amino acids and failed to form a functional polypeptide or protein. Overexpression of the mutated LAMP2 c.2T>C showed a loss of function of the protein, as assessed by the dual‐fluorescence autophagy indicator system. The mutation was confirmed to be null, AR experiments and sequencing results confirmed that 28% of the mutant X chromosome remained active. Conclusion We propose possible mechanisms of mutations associated with haploinsufficiency of LAMP2: (1) The inactivation X chromosome carrying the mutation was not significantly skewed. However, it decreased in the mRNA level and the expression ratio of the mutant transcripts; (2) The identified mutation is null, and the active mutant transcript fails to translate into the normal LAMP2 proteins. The presence of haploinsufficiency in LAMP2 and the X chromosome inactivation pattern were crucial factors contributing to the early onset of Danon disease in this female patient.
- Published
- 2023
- Full Text
- View/download PDF
24. Danon disease in a Sardinian family: different aspects of the same mutation—a case report.
- Author
-
Pasqualucci, Daniele, Maiani, Silvia, Perra, Ferdinando, Cau, Milena, Coiana, Alessandra, Bianco, Paola, Olivotto, Iacopo, and Corda, Marco
- Abstract
Background Danon disease (DD) is a rare X-linked disorder due to mutations in the lysosome-associated membrane protein 2 gene. It is characterized by a clinical triad of hypertrophic cardiomyopathy, skeletal myopathy, and a variable degree of intellectual disability. Case summary In this case series, we describe a mother and her son affected by DD, highlighting consistent clinical severity despite the expected variability related to gender. The mother (Case 1) presented isolated cardiac involvement, with an arrhythmogenic phenotype that evolved into severe heart failure requiring heart transplantation (HT). Danon disease was diagnosed 1 year after this event. Her son (Case 2) showed an earlier age onset of symptoms with complete atrioventricular block and fast progression of cardiac disease. Diagnosis was established 2 years after clinical presentation. He is currently listed for HT. Discussion In both of our patients, diagnostic delay was extremely long and could have been avoided by emphasizing the relevant clinical red flags. Patients affected by DD may present clinical heterogeneity in terms of natural history, age of onset, and cardiac and extracardiac involvement, even in the same family. Early diagnosis that phenotypic sex differences may impact is a crucial factor in managing patients with DD. Considering the rapid progression of cardiac disease and the poor prognosis, early diagnosis is important and close surveillance should be mandatory during follow-up. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Intellectual and Developmental Disabilities in Transplant Patients
- Author
-
Choi, Joy J., Vaughn, Rubiahna L., Zimbrean, Paula C., editor, Sher, Yelizaveta, editor, Crone, Catherine, editor, and DiMartini, Andrea F., editor
- Published
- 2022
- Full Text
- View/download PDF
26. 以反复肝功能异常为表现的 Danon 病 1 例报告.
- Author
-
蒲蕾蕾 and 朱蓉
- Published
- 2023
- Full Text
- View/download PDF
27. Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments.
- Author
-
Olivotto, Iacopo, Udelson, James E, Pieroni, Maurizio, and Rapezzi, Claudio
- Subjects
HEART failure ,CARDIAC amyloidosis ,VENTRICULAR ejection fraction ,CARDIOMYOPATHIES ,DRUG therapy ,HYPERTROPHIC cardiomyopathy ,PERIPHERAL circulation - Abstract
Heart failure with preserved ejection fraction (HFpEF) is a major driver of cardiac morbidity and mortality in developed countries, due to ageing populations and the increasing prevalence of comorbidities. While heart failure with reduced ejection fraction is dominated by left ventricular impairment, HFpEF results from a complex interplay of cardiac remodelling, peripheral circulation, and concomitant features including age, hypertension, obesity, and diabetes. In an important subset, however, HFpEF is subtended by specific diseases of the myocardium that are genetically determined, have distinct pathophysiology, and are increasingly amenable to targeted, innovative treatments. While each of these conditions is rare, they collectively represent a relevant subset within HFpEF cohorts, and their prompt recognition has major consequences for clinical practice, as access to dedicated, disease-specific treatments may radically change the quality of life and outcome. Furthermore, response to standard heart failure treatment will generally be modest for these individuals, whose inclusion in registries and trials may dilute the perceived efficacy of treatments targeting mainstream HFpEF. Finally, a better understanding of the molecular underpinnings of monogenic myocardial disease may help identify therapeutic targets and develop innovative treatments for selected HFpEF phenotypes of broader epidemiological relevance. The field of genetic cardiomyopathies is undergoing rapid transformation due to recent, groundbreaking advances in drug development, and deserves greater awareness within the heart failure community. The present review addressed existing and developing therapies for genetic causes of HFpEF, including hypertrophic cardiomyopathy, cardiac amyloidosis, and storage diseases, discussing their potential impact on management and their broader implications for our understanding of HFpEF at large. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Cardiovascular magnetic resonance findings in Danon disease: a case series of a family
- Author
-
Xiaolong Liu, Ning Zhai, Xiaoqiang Wang, Jiehuan Wang, Mengchun Jiang, Zhanguo Sun, Yueqin Chen, Jingjing Xu, Yinghua Cui, and Lu Li
- Subjects
Danon disease ,glycogen storage disease ,LAMP2 ,cardiovascular magnetic resonance ,late gadolinium enhancement ,feature tracking ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundCardiac involvement constitutes the primary cause of mortality in patients with Danon disease (DD). This study aimed to explore the cardiac magnetic resonance (CMR) features and progressions of DD cardiomyopathies in a family with long-term follow-up.MethodsSeven patients (five females and two males), belonging to the same family and afflicted with DD, were enrolled in this study between 2017 and 2022. The cardiac structure, function, strain, tissue characteristics on CMR and their evolutions during follow-up were analyzed.ResultsThree young female patients (3/7, 42.86%) exhibited normal cardiac morphology. Four patients (4/7, 57.14%) displayed left ventricle hypertrophy (LVH), and mostly with septal thickening (3/4, 75%). A single male case (1/7, 14.3%) showed decreased LV ejection fraction (LVEF). Nonetheless, the global LV strain of the four adult patients decreased in different degree. The global strain of adolescent male patients was decreased compared to the age-appropriate female patients. Five patients (5/7, 71.43%) exhibited late gadolinium enhancement (LGE), with proportion ranging from 31.6% to 59.7% (median value 42.7%). The most common LGE location was the LV free wall (5/5, 100%), followed by right ventricle insertion points (4/5, 80%) and intraventricular septum (2/5, 40%). Segmental radial strain (rs = −0.586), circumferential strain (r = 0.589), and longitudinal strain (r = 0.514) were all moderately correlated with the LGE proportions of corresponding segments (P
- Published
- 2023
- Full Text
- View/download PDF
29. Altered Splicing of LAMP2 in a Multigenerational Family from Latvia Affected by Danon Disease
- Author
-
Janis Stavusis, Ieva Micule, Ieva Grinfelde, Anna Zdanovica, Janis Pudulis, Sandra Valeina, Svetlana Sepetiene, Baiba Lace, and Inna Inashkina
- Subjects
LAMP2 ,Danon disease ,altered splicing ,Medicine (General) ,R5-920 - Abstract
Background and Objectives: Danon disease is a multisystemic disorder associated with variants in the LAMP2 gene, mainly affecting the cardiac muscle. Here, we report a multigenerational family from Latvia with two male patients, hemizygous for a novel splice-affecting variant c.928+3A>G. Affected patients exhibit a cardiac phenotype, moderate mental disability, and mild retinal changes. Materials and Methods: Both patients underwent either exome or hypertrophic cardiomyopathy gene panel next-generation sequencing. The pathogenic variant effect was determined using reverse transcription, Sanger sequencing, and high-resolution electrophoresis. Results: Evaluation of the splicing process revealed that approximately 80% of the transcripts exhibited a lack of the entire exon 7. This alteration was predicted to cause a shift of the reading frame, consequently introducing a premature stop codon downstream in the sequence. Conclusions: Based on our data, we propose that c.928+3A>G is a pathogenic variant associated with Danon disease.
- Published
- 2024
- Full Text
- View/download PDF
30. Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy
- Author
-
Dvornikov, Alexey V, Wang, Mingmin, Yang, Jingchun, Zhu, Ping, Le, Tai, Lin, Xueying, Cao, Hung, and Xu, Xiaolei
- Subjects
Genetics ,Heart Disease ,Cardiovascular ,Aetiology ,2.1 Biological and endogenous factors ,Animals ,Cardiomegaly ,Disease Models ,Animal ,Gene Knockout Techniques ,Glycogen Storage Disease Type IIb ,Lysosomal-Associated Membrane Protein 2 ,Myocardial Contraction ,Myocardium ,Myofibrils ,Phenotype ,Receptors ,Adrenergic ,beta ,Stroke Volume ,TOR Serine-Threonine Kinases ,Ventricular Remodeling ,Zebrafish ,Cardiomyopathy ,Danon disease ,Disease modeling ,Hypertrophic remodeling ,Cardiac contractility ,Single myofibril ,mTOR ,Cardiorespiratory Medicine and Haematology ,Medical Physiology ,Cardiovascular System & Hematology - Abstract
Adult zebrafish is an emerging vertebrate model for studying genetic basis of cardiomyopathies; but whether the simple fish heart can model essential features of hypertrophic cardiomyopathy (HCM) remained unknown. Here, we report a comprehensive phenotyping of a lamp2 knockout (KO) mutant. LAMP2 encodes a lysosomal protein and is a causative gene of Danon disease that is characterized by HCM and massive autophagic vacuoles accumulation in the tissues. There is no effective therapy yet to treat this most lethal cardiomyopathy in the young. First, we did find the autophagic vacuoles accumulation in cardiac tissues from lamp2 KO. Next, through employing a set of emerging phenotyping tools, we revealed heart failure phenotypes in the lamp2 KO mutants, including decreased ventricular ejection fraction, reduced physical exercise capacity, blunted β-adrenergic contractile response, and enlarged atrium. We also noted changes of the following indices suggesting cardiac hypertrophic remodeling in lamp2 KO: a rounded heart shape, increased end-systolic ventricular volume and density of ventricular myocardium, elevated actomyosin activation kinetics together with increased maximal isometric tension at the level of cardiac myofibrils. Lastly, we assessed the function of lysosomal-localized mTOR on the lamp2-associated Danon disease. We found that haploinsufficiency of mtor was able to normalize some characteristics of the lamp2 KO, including ejection fraction, β-adrenergic response, and the actomyosin activation kinetics. In summary, we demonstrate the feasibility of modeling the inherited HCM in the adult zebrafish, which can be used to develop potential therapies.
- Published
- 2019
31. Danon Disease Presenting as Eosinophilic Myocarditis
- Author
-
Basilio Angulo-Lara, MD, Ramón Garrido-González, MD, Clara Salas Antón, MD, PhD, Juan Francisco Oteo-Domínguez, MD, Javier Segovia-Cubero, MD, PhD, and Fernando Domínguez, MD, PhD
- Subjects
Danon disease ,endomyocardial biopsy (EMB) ,eosinophilic myocarditis ,genetic testing ,inherited cardiomyopathies ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
A 21-year-old woman with a history of atopy, peripheral eosinophilia, Wolf-Parkinson-White syndrome, and 5 episodes of myocarditis was diagnosed with eosinophilic myocarditis. Despite adequate immunosuppressive treatment and resolution of the myocarditis episode, the patient developed dilated cardiomyopathy and presented with worsening of her functional class. Finally, genetic testing unveiled an additional diagnosis: Danon disease. (Level of Difficulty: Advanced.)
- Published
- 2023
- Full Text
- View/download PDF
32. Red flags to diagnose infiltrative cardiomyopathies
- Author
-
E. V. Reznik, T. L. Nguyen, D. V. Ustyuzhanin, A. N. Semyachkina, and M. A. Shkolnikova
- Subjects
infiltrative heart diseases ,infiltrative cardiomyopathies ,red flags ,diagnostic keys ,amyloidosis ,sarcoidosis ,hemochromatosis ,fabry disease ,mucopolysaccharidosis ,danon disease ,pompe disease ,heart failure ,arrhythmia ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Infiltrative cardiomyopathies are a group of diseases characterized by the deposition of abnormal substances in heart tissues, which leads to thickening of the walls or dilation of chambers with a secondary decrease in wall thickness and the development of diastolic, less often systolic, ventricular dysfunction. Most often, these are progressive diseases that, in the absence of adequate therapy, have an unfavorable prognosis. Clinical manifestations of infiltrative cardiac diseases are variable, which often leads to diagnostic difficulties and errors. In most cases, specific laboratory and morphological tests are required to confirm or clarify the diagnosis. Early diagnosis is critical to initiating therapy and improving patient prognosis. This article provides characteristic signs and symptoms, the so-called "red flags", making it possible to suspect infiltrative cardiomyopathies, diagnose them at an early stage and start life-saving therapy.
- Published
- 2023
- Full Text
- View/download PDF
33. Metabolic Maturation Exaggerates Abnormal Calcium Handling in a Lamp2 Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease.
- Author
-
Barndt, Robert J., Liu, Qing, Tang, Ying, Haugh, Michael P., Cui, Jeffery, Chan, Stephen Y., and Wu, Haodi
- Subjects
- *
ARRHYTHMIA , *CARDIAC hypertrophy , *CALCIUM , *CARDIAC arrest , *REACTIVE oxygen species , *CALCIUM channels - Abstract
Danon disease (DD) is caused by mutations of the gene encoding lysosomal-associated membrane protein type 2 (LAMP2), which lead to impaired autophagy, glycogen accumulation, and cardiac hypertrophy. However, it is not well understood why a large portion of DD patients develop arrhythmia and sudden cardiac death. In the current study, we generated LAMP2 knockout (KO) human iPSC-derived cardiomyocytes (CM), which mimic the LAMP2 dysfunction in DD heart. Morphologic analysis demonstrated the sarcomere disarrangement in LAMP2 KO CMs. In functional studies, LAMP2 KO CMs showed near-normal calcium handling at base level. However, treatment of pro-maturation medium (MM) exaggerated the disease phenotype in the KO cells as they exhibited impaired calcium recycling and increased irregular beating events, which recapitulates the pro-arrhythmia phenotypes of DD patients. Further mechanistic study confirmed that MM treatment significantly enhanced the autophagic stress in the LAMP2 KO CMs, which was accompanied by an increase of both cellular and mitochondrial reactive oxygen species (ROS) levels. Excess ROS accumulation in LAMP2 KO CMs resulted in the over-activation of calcium/calmodulin dependent protein kinase IIδ (CaMKIIδ) and arrhythmogenesis, which was partially rescued by the treatment of ROS scavenger. In summary, our study has revealed ROS induced CaMKIIδ overactivation as a key mechanism that promotes cardiac arrhythmia in DD patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Autophagic vacuolar myopathy: Danon disease and related myopathies.
- Author
-
Sugie, Kazuma
- Subjects
- *
AUTOPHAGY , *MUSCLE diseases , *HYPERTROPHIC cardiomyopathy , *HEART transplantation , *MEMBRANE proteins - Abstract
Autophagic vacuolar myopathy is a subgroup of muscle diseases defined as a condition in which autophagic vacuoles are present as a muscle pathological feature and is caused by abnormality of autophagy in skeletal muscles. There is an autophagic vacuolar myopathy characterized by the presence of specific autophagic vacuoles known as autophagic vacuoles with sarcolemmal features (AVSF). It is referred to as AVSF myopathy and includes Danon disease and related myopathies. Danon disease is an X‐linked dominant disease associated with a primary deficiency of lysosomal‐associated membrane protein 2 in which severe hypertrophic cardiomyopathy and myopathy develop. Cardiomyopathy is a determinant prognostic factor of this disease, and heart transplantation is still the sole radical treatment. The pathomechanism of AVSF myopathy is considered to be caused by abnormality of autophagy resulting from primary lysosomal dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. DANON DISEASE: A MODEL OF PHOTORECEPTOR DEGENERATION SECONDARY TO PRIMARY RETINAL PIGMENT EPITHELIUM DISEASE.
- Author
-
O'Neil, Erin C., Uyhazi, Katherine E., O'Connor, Keli, Aleman, Isabella A., Pulido, Jose S., Rossano, Joseph W., and Aleman, Tomas S.
- Abstract
Supplemental Digital Content is Available in the Text. A detailed retinal phenotype of three patients with Danon disease, a systemic disease with cardiovascular, muscular, cognitive, and ophthalmic manifestations, demonstrating age-dependent loss of near-infrared fundus autofluorescence signals and rod photoreceptor abnormalities in a pattern consistent with other primary retinal pigment epithelial or parallel retinal pigment epithelial and photoreceptor disease. Purpose: To describe in detail the retinal phenotype of LAMP2 -associated Danon disease. Methods: Three LAMP2 -positive patients from two unrelated families were studied with spectral-domain optical coherence tomography and with short-wavelength and near-infrared fundus autofluorescence (FAF) imaging. Visual function was measured with full-field electroretinography and chromatic perimetry. A patient with choroideremia was also studied for comparison. Results: A 45-year-old LAMP2 -heterozygous woman, her 21-year-old hemizygous son, and an unrelated heterozygous 60-year-old woman had normal visual acuities. Central spectral-domain optical coherence tomographies were grossly normal in the younger two patients (mother and son). The oldest patient showed a tenuous interdigitation signal, interruptions of the inner segment ellipsoid zone band, and parafoveal outer nuclear layer thinning. Quantitatively, all patients had shorter than normal ellipsoid zone to retinal pigment epithelium distance in pericentral retina, normal at the foveola. A speckled hypoautofluorescence pattern on short-wavelength FAF contrasted with grossly abnormal near-infrared FAF in the heterozygous carriers. The oldest patient had reduced full-field electroretinography amplitudes (to ∼50% of normal) for rod- and cone-mediated responses and her perimetry showed severe rod dysfunction but substantial cone function. A disproportionate loss of the near-infrared FAF compared with the short-wavelength FAF, predominantly outer segment changes, and severe rod dysfunction with preserved cone function was similarly documented in a 9-year-old choroideremia hemizygous patient. Conclusion: A disproportionate loss of the near-infrared FAF signal compared with the short-wavelength FAF signal, outer segment abnormalities, and severe rod dysfunction but relatively preserved cone vision suggests a stereotypical pattern of primary retinal pigment epithelial or parallel retinal pigment epithelial + photoreceptor disease in Danon disease. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement
- Author
-
Anna Burban, Szymon Pucyło, Aleksandra Sikora, Grzegorz Opolski, Marcin Grabowski, and Agnieszka Kołodzińska
- Subjects
hypertrophic cardiomyopathy ,Fabry disease ,Pompe disease ,Danon disease ,genetics ,gene therapies ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
One of the main causes of heart failure is cardiomyopathies. Among them, the most common is hypertrophic cardiomyopathy (HCM), characterized by thickening of the left ventricular muscle. This article focuses on HCM and other cardiomyopathies with myocardial hypertrophy, including Fabry disease, Pompe disease, and Danon disease. The genetics and pathogenesis of these diseases are described, as well as current and experimental treatment options, such as pharmacological intervention and the potential of gene therapies. Although genetic approaches are promising and have the potential to become the best treatments for these diseases, further research is needed to evaluate their efficacy and safety. This article describes current knowledge and advances in the treatment of the aforementioned cardiomyopathies.
- Published
- 2023
- Full Text
- View/download PDF
37. Danon Disease Presenting with Slowly Progressive Cardiomyopathy and Harboring a Novel Missense Variant in the Lysosome-associated Membrane Protein Type 2 (LAMP-2) gene: A Case Report.
- Author
-
Nakagawa Y, Hayashi K, Tada T, Asakawa M, Yoshida S, Nomura A, Miwa K, Furusho H, Takamura M, and Yasuda T
- Abstract
Danon disease (DD) is a rare lysosomal storage disorder resulting from pathogenic variants of the lysosome-associated membrane protein type 2 (LAMP-2) gene. The disease is characterized by severe cardiomyopathy, which rapidly progresses to end-stage heart failure. This case, with DD caused by a missense variant, exhibited slow progressive cardiomyopathy and survived for an extended period despite being a male. A pathological analysis revealed that only a minority of the samples exhibited autophagic vacuoles with unique sarcolemmal features (AVSFs), which are typical of DD. Importantly, LAMP-2 expression was absent and the myocardial tissue contained a substantial amount of p62-positive aggregates.
- Published
- 2024
- Full Text
- View/download PDF
38. De novo LAMP2 insertion mutation causes cardiac-only Danon disease: A case report
- Author
-
James Jiqi Wang, Bo Yu, Xiuli Song, and Hong Wang
- Subjects
Danon disease ,Sanger sequencing ,genetic diagnosis ,LAMP2 ,hypertrophy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Danon disease is a rare disease caused by glycogen storage lysosomal disorder. It is related to the pathogenic mutation of the LAMP2 gene. In this case report, we present a patient with a novel pathogenic mutation (c.764_765insGA) with cardiac-only symptoms. Her family members do not carry the same mutation she does, suggesting this is a de novo mutation. Further tests revealed vacuoles and glycogen disposition in the patient's heart tissue and a significant decrease in LAMP2 protein expression. Protein structure remodeling of LAMP2 predicted that the mutant protein has conformational change lacking an important transmembrane domain, subsequently causing protein destabilization.
- Published
- 2022
- Full Text
- View/download PDF
39. Danon Disease: Entire LAMP2 Gene Deletion with Unusual Clinical Presentation—Case Report and Review of the Literature
- Author
-
Adel Shalata, Marina Bar-Shai, Yarin Hadid, Muhammad Mahroum, Hila Mintz, Zaher Eldin Shalata, Evgeny Radzishevsky, Jacob Genizi, Avraham Lorber, Tamar Ben-Yosef, and Liat Yaniv
- Subjects
Danon disease ,LAMP2-gene ,genotype-phenotype correlation ,penetrance ,microdeletion ,whole-exome-sequence ,Genetics ,QH426-470 - Abstract
Danon disease is a rare x-linked dominant multisystemic disorder with a clinical triad of severe cardiomyopathy, skeletal myopathy, and intellectual disability. It is caused by defects in the lysosome-associated membrane protein-2 (LAMP2) gene. Numerous different mutations in the LAMP2 protein have been described. Danon disease is typically lethal by the mid-twenties in male patients due to cardiomyopathy and heart failure. Female patients usually present with milder and variable symptoms. This report describes a 42-year-old father and his 3-year-old daughter presenting with mild manifestations of the disease. The father has normal intellectual development and normal physical activity. At the age of 13, he was diagnosed with mild ventricular pre-excitation known as Wolf–Parkinson–White syndrome (WPWs), very mild and mostly asymptomatic cardiomyopathy and left ventricular hypertrophy, and at about the age of 25 presented with visual impairment due to cone–rod dystrophy. His daughter showed normal development and very mild asymptomatic electrocardiographic WPWs abnormalities with left mild ventricular hypertrophy. Genetic testing revealed an Xq24 microdeletion encompassing the entire LAMP2 gene. Relevant literature was reviewed as a reference for the etiology, diagnosis, treatment and case management.
- Published
- 2023
- Full Text
- View/download PDF
40. Danon disease: a case report and literature review
- Author
-
Jiamin Xu, Zhu Li, Yihai Liu, Xinlin Zhang, Fengnan Niu, Hongyan Zheng, Lian Wang, Lina Kang, Kun Wang, and Biao Xu
- Subjects
Danon disease ,Cardiomyopathy ,LAMP2 ,Mutation ,NGS ,Pathology ,RB1-214 - Abstract
Abstract Background Danon disease (DD) is a rare x-linked dominant multisystemic disorder with a clinical triad of severe cardiomyopathy, skeletal myopathy, and mental retardation. It is caused by a defect in the lysosomal-associated membrane protein-2 (LAMP2) gene, which leads to the formation of autophagic vacuoles containing glycogen granule deposits in skeletal and cardiac muscle fibers. So far, more than 50 different mutations in LAMP2 have been identified. Case presentation Here, we report an 18-year-old male patient who was hospitalized for heart failure. Biopsy of the left lateral femoral muscle revealed scattered autophagic vacuoles in the muscle fibers with increased glycogen. Next generation sequencing (NGS) was used to detect gene mutations of the proband sample and a novel frameshift mutation (c.1052delG) has been identified in exon 8 of LAMP2, which leads to truncation of the protein. Conclusion We found a novel frameshift mutation, a hemizygous mutation (c.1052delG) in exon 8 of LAMP2, identified as presenting the hypertrophic cardiomyopathy (HCM) phenotype. Genetic analysis is the gold standard for the diagnosis of DD and is essential to determine appropriate treatment strategies and to confirm the genetic risk of family members.
- Published
- 2021
- Full Text
- View/download PDF
41. Case Report: Danon Disease: Six Family Members and Literature Review
- Author
-
Yuanyuan Wang, Meixue Jia, Yingjie Guo, Ting Zhang, and Bin Ning
- Subjects
case report ,Danon disease ,lysosome-associated membrane 2 ,ventricular hypertrophy ,pre-excitation ,liver injury ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Danon disease is a rare X-linked dominant genetic disorder that manifests with a clinical triad of cardiomyopathy, skeletal myopathy, and intellectual disability. It is caused by mutations in the lysosome-associated membrane 2 (LAMP2) gene. We report one case of Danon disease and his family members, characterized by ventricular pre-excitation, ventricular hypertrophy, abnormal muscle enzymes, and aberrant liver function. All the patients were confirmed to have Danon disease through genetic screening. Relevant literature was reviewed as a reference for the diagnosis and treatment of the disease.
- Published
- 2022
- Full Text
- View/download PDF
42. Danon disease manifesting as dilated cardiomyopathy in a 37-year-old woman.
- Author
-
Li, Xinglu, Li, Jinghui, and Lu, Minjie
- Subjects
TROPONIN ,WOMEN ,CARDIOMYOPATHIES ,INBORN errors of carbohydrate metabolism ,ELECTRON microscopy ,DILATED cardiomyopathy ,ELECTROCARDIOGRAPHY ,BRADYCARDIA ,DYSPNEA ,NATRIURETIC peptides ,ECHOCARDIOGRAPHY ,PHENOTYPES ,ADULTS - Published
- 2024
- Full Text
- View/download PDF
43. Cardiac Transplantation in Danon Disease.
- Author
-
Hong, Kimberly N., Battikha, Carol, John, Sonya, Lin, Andrew, Bui, Quan M., Brambatti, Michela, Storm, Garrett, Boynton, Kylie, Medina-Hernandez, Danielle, Garcia-Alvarez, Ana, Castel, Maria Angeles, Garcia-Guereta, Luis, Diez Lopez, Carles, Perez-Gomez, Laura, Miani, Daniela, Symanski, John D., Taylor, Matthew R., Garcia-Pavia, Pablo, and Adler, Eric D.
- Abstract
Background: Danon disease (DD) is a rare X-linked dominant cardioskeletal myopathy caused by mutations in the lysosome-associated membrane protein-2 (LAMP-2) gene that is usually lethal without cardiac transplantation. The purpose of this study was to characterize post-transplant outcomes in a large cohort of patients with DD who underwent cardiac transplantation.Methods: The clinical phenotype and outcome data of patients with DD who underwent cardiac transplantation (n = 38; 19 males and 19 females) were obtained from 8 centers. Study outcomes included graft survival, defined as death or retransplantation, and episodes of acute cellular and antibody-mediated rejection and cardiac allograft vasculopathy at 1 year.Results: Median follow-up time after transplantation for the entire cohort was 4.4 years (IQR: 1.5-12.8 years). The median age at transplant for the cohort was 20.2 years (15.8-27.9 years), with no difference in age between sexes. Median pretransplant left-ventricular ejection fraction for the entire cohort was 30% (range 11%-84%). Males had higher pretransplant aspartate aminotransferase, alanine aminotransferase and creatine phosphokinase levels than females (P < 0.001). There were 2 deaths in the entire cohort and 2 retransplants. There was no difference in actuarial graft survival between males and females (P = 0.8965); the estimated graft survival was 87.1% (95%CI: 63.6%-95.9%) at 5 years. One episode (2.7%) of antibody-mediated rejection, grade 2, and 7 episodes (19%) of acute cellular rejection, grade 2 or 3, were reported in patients who survived to discharge (6 females and 1 male; P = 0.172).Conclusions: Heart transplantation outcomes are acceptable in DD with high probabilities of 5-year graft survival for males and females suggesting that cardiac transplantation is an effective treatment option for DD patients. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
44. Cardiomyopathies
- Author
-
Bunning, Clare R., Suvarna, S. Kim, and Suvarna, S. Kim, editor
- Published
- 2019
- Full Text
- View/download PDF
45. A new UHPLC-MS/MS method for the screening of urinary oligosaccharides expands the detection of storage disorders
- Author
-
Michela Semeraro, Elisa Sacchetti, Federica Deodato, Turgay Coşkun, Incilay Lay, Giulio Catesini, Giorgia Olivieri, Cristiano Rizzo, Sara Boenzi, and Carlo Dionisi-Vici
- Subjects
Oligosaccharides ,Storage disorders ,Pompe disease ,Autophagy ,Danon disease ,Vici syndrome ,Medicine - Abstract
Abstract Background Oligosaccharidoses are storage disorders due to enzymatic defects involved in the breakdown of the oligosaccharidic component of glycosylated proteins. The defect cause the accumulation of oligosaccharides (OS) and, depending on the lacking enzyme, results in characteristic profiles which are helpful for the diagnosis. We developed a new tandem mass spectrometry method for the screening of urinary OS which was applied to identify a large panel of storage disorders. Methods The method was set-up in urine and dried urine spots (DUS). Samples were analysed, without derivatization and using maltoheptaose as internal standard, by UHPLC-MS/MS with MRM acquisition of target OS transitions, including Glc4, the biomarker of Pompe disease. The chromatographic run was
- Published
- 2021
- Full Text
- View/download PDF
46. Relationship Between Fragmented QRS Complex and Left Ventricular Fibrosis and Function in Patients With Danon Disease
- Author
-
Jiajun Xie, Yang Liu, Xiaoyu Wei, Weitao Ye, Zelan Ma, Guanyu Lu, Zekun Tan, Tingyu Li, Yining Wang, Lei Zhao, Minjie Lu, Xiaohu Li, Yucheng Chen, and Hui Liu
- Subjects
Danon disease ,myocardial fibrosis ,electrocardiography ,fragmented QRS ,cardiac magnetic resonance imaging (CMR) ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundFragmented QRS (f-QRS) complex on the surface ECG is a cardiac conduction abnormality that indicates myocardial scarring. The relationship between the f-QRS complex and cardiac status in patients with Danon disease (DD) remains unclear and will be explored in this study.MethodsPatients with genetically confirmed DD and cardiac magnetic resonance imaging (CMR) examinations were recruited from multiple centers. The number of leads, pattern, score, and segmental distribution of the f-QRS complex were assessed by surface 12-lead ECG. Cardiac status, such as left ventricular (LV) volume, function, and extent of late gadolinium enhancement (LGE), was demonstrated by CMR. The segmental distribution of LGE was also assessed. Correlations between the f-QRS and cardiac status were assessed.ResultsFifteen patients (14 men) with DD who underwent 12-lead ECG and CMR imaging were included. The f-QRS complex was documented in all patients (n = 15, 100%). Three patterns of f-QRS were found, with the notched R/S pattern (74%) being the most common, followed by fragmented QRS (16%) and various RSR' (11%). The fragmented QRS pattern showed an association with a higher level of myocardial fibrosis (LGE > 35%). The burden of f-QRS in each patient was assessed by the number of leads with f-QRS (median 7, range 2–12) and the f-QRS score (median 9, range 2–33). In the correlation analysis, the f-QRS score was positively correlated with LGE% (r = 0.726, p = 0.002), negatively correlated with LV ejection function (LVEF; r = −0.617, p = 0.014) as evaluated by CMR. In the local distribution, f-QRS score and LGE% were both predominant in the LV free wall but did not correlate well among the anterior, lateral, and inferior segments.ConclusionIn this DD cohort, the quantitative f-QRS was correlated well with myocardial fibrosis burden and LV dysfunction in general. This finding suggests that f-QRS can be used as a simple screening tool to assess cardiac status in patients with DD.
- Published
- 2022
- Full Text
- View/download PDF
47. Four-dimensional echocardiography and left ventricular systolic strain measured via two-dimensional speckle-tracking for Danon disease: a case series.
- Author
-
Changsheng, Ma, Fan, Jiali, Bingyuan, Zhou, Jiawei, Zhou, Li, Wang, Lin, Fan, Yuping, Liao, and Caiming, Zhao
- Subjects
LEFT ventricular hypertrophy ,SPECKLE tracking echocardiography ,VENTRICULAR ejection fraction ,LEFT heart atrium ,HEART fibrosis ,PATIENTS' rights - Abstract
Background Danon disease is an X-linked multisystemic disorder characterized by skeletal myopathy, cardiomyopathy, and intellectual disability. Case summary Herein, we describe two patients affected by Danon disease from the same family, a father (Patient 1) and his daughter (Patient 2). In Patient 1, a short PR interval with pre-excitation was evident. In Patient 2, over a 24-h period 2369 atrial premature beats and rare isolated ventricular ectopics were detected. Both patients exhibited left ventricular hypertrophy with non-compaction myocardium, and the left ventricular ejection fraction was impaired in Patient 1 and normal in Patient 2. In Patient 2, the total left ventricular strain value was reduced, and layer-specific strain revealed that subepicardial strain impaired more than in other layers. Late gadolinium enhancement was detected both in left and right ventricles in Patient 2, and cardiac fibrosis was more apparent in the subepicardium of left ventricular free wall. Four-dimensional (4D) echocardiography revealed that left atrial reservoir strain and left ventricular total longitudinal strain were induced. Discussion Novel 4D echocardiography and left ventricular systolic strain may play important role in diagnosis and myocardial functional evaluation in Danon disease. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
48. Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study
- Author
-
Jiri Gurka, Lenka Piherova, Filip Majer, Anna Chaloupka, Daniela Zakova, Ondrej Pelak, Alice Krebsova, Petr Peichl, Jan Krejci, Tomas Freiberger, Vojtech Melenovsky, Josef Kautzner, Tomas Kalina, Jakub Sikora, and Milos Kubanek
- Subjects
Advanced heart failure ,Danon disease ,Lysosomal‐associated membrane protein type 2 ,Screening ,White blood cells ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims Danon disease (DD) is a rare X‐linked disorder caused by mutations in the lysosomal‐associated membrane protein type 2 gene (LAMP2). DD is difficult to distinguish from other causes of dilated or hypertrophic cardiomyopathy (HCM) in female patients. As DD female patients regularly progress into advanced heart failure (AHF) aged 20–40 years, their early identification is critical to improve patient survival and facilitate genetic counselling. In this study, we evaluated the prevalence of DD among female patients with non‐ischemic cardiomyopathy, who reached AHF and were younger than 40 years. Methods and results The study cohort comprised 60 female patients: 47 (78%) heart transplant recipients, 2 (3%) patients treated with ventricular assist device, and 11 (18%) patients undergoing pre‐transplant assessment. Aetiology of the cardiomyopathy was known in 15 patients (including two DD patients). LAMP2 expression in peripheral white blood cells (WBC) was tested by flow cytometry (FC) in the remaining 45 female patients. Whole exome sequencing was used as an alternative independent testing method to FC. Five additional female DD patients (two with different novel LAMP2 mutations) were identified by FC. The total prevalence of DD in this cohort was 12%. HCM phenotype (57% vs. 9%, *P = 0.022) and delta waves identified by electrocardiography (43% vs. 0%, **P = 0.002) were significantly more frequent in DD female patients. Conclusions Danon disease is an underdiagnosed cause of AHF in young female patients. LAMP2 expression testing in peripheral WBCs by FC can be used as an effective screening/diagnostic tool to identify DD in this patient population.
- Published
- 2020
- Full Text
- View/download PDF
49. Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis 'Amyloidosis' as a Manifestation of Danon Disease in a Woman
- Author
-
O. V. Blagova, E. A. Kogan, V. P. Sedov, Yu. A. Lutokhina, A. V. Nedostup, A. V. Ott, L. M. Dashinemaeva, and E. V. Zaklyazminskaya
- Subjects
hypertrophic cardiomyopathy ,danon disease ,amyloidosis ,endomyocardial biopsy ,atrial fibrillation ,Therapeutics. Pharmacology ,RM1-950 ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Aim. To analyze the difficulties of diagnosis and the clinical features of the Danon disease in women.Results. An observation of Danon disease in a woman aged 18 years with an uncomplicated family history is presented. The early development of atrial fibrillation (at the age of not more than 15 years) in combination with atrioventricular blockade against the background of regular sports was not attracted due attention for 3 years. The examination revealed: a moderate degree of left ventricular hypertrophy (up to 17 mm), its diffuse nature and simultaneous involvement of the right ventricle, signs of heart failure due to severe restrictive disorders with preserved ejection fraction. Cardiac magnetic resonance imaging data (non-specific late gadolinium enhancement) became the basis for the assumption of amyloidosis and the implementation of a myocardial biopsy. An erroneous diagnosis of cardiac amyloidosis according to myocardial biopsy was refuted during a second study, the PAS reaction revealed signs of storage disease. The diagnosis of Danon disease was verified using DNA diagnostics (c.731delG mutation was detected). Due to the presence of unsustained paroxysmal ventricular tachycardia and a high calculated risk of sudden death, cardioverter-defibrillator was implanted. The analysis of literature data on the frequency and the manifestation of Danon disease in women, the place of this disease in the structure of the causes of myocardial hypertrophy is given.Conclusion. Atrial fibrillation at a young age and left ventricular hypertrophy syndrome can develop due to primary myocardial diseases not well known in the practice of a cardiologist. They require an in-depth diagnostic search; their identification is critical for determining treatment tactics and prognosis.
- Published
- 2020
- Full Text
- View/download PDF
50. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report
- Author
-
Valeria Novelli, Antonio Bisignani, Gemma Pelargonio, Guido Primiano, Maria Lucia Narducci, Vincenzo Palmieri, Francesco Danilo Tiziano, Paolo Zeppilli, Serenella Servidei, Filippo Crea, and Maurizio Genuardi
- Subjects
Danon disease ,Genetic testing ,Pathogenic variants ,Hypertrophic cardiomyopathy ,Phenocopy ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Danon disease (OMIM 300257) is an X-linked lysosomal storage disorder, characterized by hypertrophic cardiomyopathy (HCM), skeletal myopathy, variable intellectual disability, and other minor clinical features. This condition accounts for ~ 4% of HCM patients, with a more severe and early onset phenotype in males, causing sudden cardiac death (SCD) in the first three decades of life. Genetic alterations in the LAMP2 gene are the main cause of this inherited fatal condition. Up to date, more than 100 different pathogenic variants have been reported in the literature. However, the majority of cases are misdiagnosed as HCM or have a delay in the diagnosis. Case presentation Here, we describe a young boy with an early diagnosis of HCM. After 2 episodes of ventricular fibrillation within 2 years, genetic testing identified a novel LAMP2 pathogenic variant. Subsequently, further clinical evaluations showing muscle weakness and mild intellectual disability confirmed the diagnosis of Danon disease. Conclusions This report highlights the role of genetic testing in the rapid diagnosis of Danon disease, underscoring the need to routinely consider the inclusion of LAMP2 gene in the genetic screening for HCM, since an early diagnosis of Danon disease in patients with a phenotype mimicking HCM is essential to plan appropriate treatment, ie cardiac transplantation.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.